Sylvia Kang

Sylvia is committed to bringing point-of-care technology to improve consumers’ health. Mira (miracare.com) is the first FDA, CE, and CFDA registered comprehensive women’s health monitoring platform with 99% of accuracy in clinical trials. Mira tracks cycles, predicts ovulation, monitors fetal health, measures ovarian reserve and detects menopause at home, using the hospital-leveled technology within a palm-sized device. The data automatically syncs to the Mira app. The AI learns personal health patterns. The telemedicine connects users with doctors. Sylvia has significant P&L general management experiences. She has taken business and product director roles in a Fortune 500 life science company, running a $100M global business. Sylvia holds an MBA from Cornell University, and a MS i...